Document 6bb7289gMa7eZaV425VLawR36

December 5 1970 M r. F , F . Roaseh CTFA Siiheemmftto Mating on Asbestos n Taie S 1 Tho meeting was held st Bristol-Myers, Hlllstdo on ttecembr 4, 1974. Those In attendance IncJuded: Or. Joseph SliBka (Colaate) fcr, Harold Stanley (Pfteer) Mr. George Sandland (BrlstfHayera, ChiiErman) Mr. Georgs Cohort (Bristol-Myers) jj Mr. Allan Hctrvoy (Vartdarbllt} Dr. Robert Roll <JU) Dr. George Lee (4SJ1 Or, John Travers (Avon} J&J pushed for the commute to submit the attached methods for consideration by the FDA. This was opposed by most members (Avon and Vanderbilt rmstried neutral) on the grounds that the work had been parforracd ij toy only Avon and J&I. Reportedly* fctennen and Chesabrough-Ponds have DTA equipment but they have not started to examine the samples. Colgate ami Pfirar have OTA equipment ordered but as yet do not I even know the date of delivery. J t told the group of our OTA werk at Debait and Richardson where we had 3 samples examined. For our Information those were Identified asi A. #4609 Talc; B, $3965 Tate; C. #4699 Talc. Etebell and Richardson had reported sample i!Ae (4169) to contain chrysolite because It had e p&k at 850 degrees C. Of. Relic felt dial this was m t proof af the presence of chrysolite because there must be two peaks (another at 650 degrees C ). We hsva agreed to submit another three blind samples to Ctebeil 3 Richardson for additional DTA work. We will receive these from Rolls PsJ>. It was reported toy JSJ and also toy Avon that the FDA ha never Identified chrysolite In any ti. S. cosmetic talc. PLAINTIFFS EXHIBIT WCD-386 continued....... Goodhue WCD 000139 fyts .j December 5, 1974 Mr. F, F. Reesch CTFA Subcommittee Meeting en Asber in Talc Fflzr feats that DTA la being pu had by JSJ because the FDA has similar equipment but they do not have an electron microscope. I feet that Pfizer Is correct in this attitude but two different types of personnel are Involved. ttta lw s much greater sk ill to operate the electron microscope than It does to operate the OTA. t-4' Ii i fteporfejy, the FDA has commissioned the Franklin Institute. Philadelphia start a research study of asbestos and talc. The onset meeting,, to be held at Bristol-Myers, has been tentatively set for Tuesday February 4, 1975. In the meantime, Mr, Ssndtand wilt try to set up an inferwatlsnal type meeting with Herman Estrln (CTFA), r.V '?E. ,, fj ; Vi-r, ''.'i ' cA* "; HT " R R K /m w Ray ft. Krammes Goodhue WCD 000140